Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

CB2 agonists show potential for the treatment of kidney disease

Sep. 9, 2014

FDA approves Keryx Biopharmaceuticals' ferric citrate

Sep. 8, 2014

Tricida confirms new clinical candidate for cardiorenal disease

Sep. 8, 2014

Velphoro receives marketing authorization in Europe

Aug. 28, 2014

La Jolla Pharmaceutical initiates phase I/II trial of LJPC-501 in hepatorenal syndrome

Aug. 26, 2014

Mitsubishi Tanabe Pharma and AstraZeneca form diabetic nephropathy collaboration

Aug. 21, 2014

Allergan acquires lidocaine for interstitial cystitis/bladder pain syndrome

Aug. 14, 2014

CHBP and caspase-3 siRNAs for renoprotection against ischemia reperfusion and CsA nephrotoxicity

Aug. 4, 2014

Phase II results presented for siRNA drug for the prophylaxis of DGF

Aug. 1, 2014

Targacept discontinues TC-5214 for overactive bladder

July 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...